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Abstract 
Redox signaling in the colonic mucosa is held in an intricate balance. Potent microbicidal mechanisms can be used 
by infiltrating immune cells, such as neutrophils, to protect compromised mucosae from microbial infection through 
the generation of reactive oxygen species. Unchecked, collateral damage to the surrounding tissue from neutrophil-
derived reactive oxygen species and can be detrimental, and thus, maintenance and restitution of a breached 
intestinal mucosal barrier are paramount to host survival. Redox reactions and redox signaling have been studied for 
decades with a primary focus on contributions to disease processes. Within the past decade an upsurge of exciting 
findings have implicated sub-toxic levels of oxidative stress in processes such as, maintenance of mucosal 
homeostasis, the control of protective inflammation and even regulation of tissue wound healing. Resident gut 
microbial communities have been shown to trigger redox signaling within the mucosa, which expresses similar but 
distinct enzymes to phagocytes. At the fulcrum of this delicate balance is the colonic mucosal epithelium and 
emerging evidence suggests that precise control of redox signaling by these barrier-forming cells may dictate the 
outcome of an inflammatory event. This Review will address both the spectrum and intensity of redox activity 
pertaining to host-immune and host-microbiota crosstalk during homeostasis and disease processes in the 
gastrointestinal tract.  
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Key points 
• Immune cells, microorganisms and the epithelium all generate and respond to redox signals in the colonic 
mucosa during homeostasis and in disease 
• Redox signals, particularly H2O2, are generated by the host and the gut microbiota to impede overgrowth of 
opportunistic pathogens; similarly, certain pathogens utilize these systems to subvert host defences 
• Host responses to reactive oxygen species (ROS) produced in situ and hypoxia act in concert and opposition to 
regulate homeostasis in the gut. 
• Host-immune and host-microbiota crosstalk can both contribute to excessive ROS production, participating in 
collateral damage at the tissue level. 
 
 
[H1] Introduction  
 
Mucosae are selectively permeable host surfaces, necessary for interaction with the environment and for facilitating 
crucial functions including gaseous exchange and nutrient absorption1. Protecting these surfaces from both 
pathogenic and commensal microorganisms while maintaining immune homeostasis requires the ability to rapidly 
and potently induce danger signals when appropriate and to promptly neutralize these signals to limit collateral 
damage to the mucosa. The colonic mucosa consists of a single layer of epithelia derived from the crypt stem cell 
niche. As crypt stem cells proliferate, daughter cells migrate along the crypt axis, differentiating into specialized 
epithelia of either secretory or absorptive lineages2. Absorptive enterocytes are responsible for water reabsorption, 
whereas secretory epithelia are tasked with mucus and antimicrobial peptide (AMP) secretion into the lumen of the 
gut 2,3. These secretions provide an essential carbon source for the microbial niche, in terms of glycosylated mucins, 
but they also maintain a sterile margin directly adjacent to the epithelial cells to prevent inappropriate responses to 
resident gut microbiota 4,5.  
 Immune and inflammatory responses within the gastrointestinal mucosae are characterized by profound 
shifts in tissue metabolism. These changes include the utilization of large amounts of energy and diminished 
availability of oxygen (hypoxia) 6.  Such shifts in tissue metabolism result, at least in part, from recruitment of 
inflammatory cells, particularly neutrophils (PMN) and monocytes7. A particularly prominent phenotype of acute 
inflammatory lesions within the intestine is localized accumulation of PMN, termed crypt abscesses.  Given the 
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large amounts of reactive oxygen species (ROS) that can be generated by activated PMN, the crypt abscess 
represents a major signaling node for reduction-oxidation (redox) signaling8.   Resident immune cells in the 
intestine, which include intra-epithelial lymphocytes and professional antigen presenting cells (dendritic cells and 
macrophages), are poised as sentinels to respond to host threats such as bacterial and viral infections but also 
contribute to homeostasis by immune surveillance and promoting a regulatory immune response 9-11. Most of these 
cell types – immune, epithelia and microorganism — are capable of eliciting and/or circumventing redox signaling 
with profound implications for mucosal homeostasis.     
A significant result of active inflammation in the intestinal mucosae is the localized conversion of 
molecular O2 to ROS and resultant hypoxia. At the tissue and cellular level, hypoxia induces an array of genes 
pivotal to adaptation to low O2 states. As a global regulator of O2 homeostasis, the αβ heterodimeric transcription 
factor hypoxia-inducible factor (HIF) facilitates both O2 delivery and adaptation to hypoxia12,13. HIF-1 and HIF-2 
(previously called EPAS) are members of the Per-ARNT-Sim (PAS) family of basic helix-loop-helix (bHLH) 
transcription factors. HIF activation is dependent upon stabilization of an O2-dependent degradation (ODD) domain 
of the α subunit and subsequent nuclear translocation to form a functional complex with HIF-1β and cofactors such 
as CBP and its ortholog p300.  When O2 supply exceeds demand, iron and O2 dependent hydoxylation of two 
prolines (Pro564 and Pro 402) within the ODD of HIF-1 or HIF-2α initiates the association with the von Hippel-
Lindau tumor suppressor protein (pVHL) and degradation via ubiquitin-E3 ligase proteasomal targeting 14,15. A 
second hypoxic switch operates in the carboxy terminal transactivation domain of HIF-1 or HIF-2α Here, hypoxia 
blocks the hydroxylation of asparagine-803 so facilitating the recruitment of CBP/p300 16.  
A unique feature of the intestinal mucosa, particularly the colon, is the juxtaposition to large numbers of 
microorganisms, termed the gut microbiota. Indeed, the mammalian gastrointestinal tract is home to >1013 
microorganisms, which approximates the number of eukaryotic cells comprising the human body 17. The epithelium, 
a single layer of specialized absorptive and secretory cells, is all that separates this biomass from the host immune 
system 18. A finely regulated relationship exists within the intestinal mucosa, whereby microorganisms, essential for 
host health, can also initiate and perpetuate mucosal disease 19. Nutrient provision by microbes is one benefit to the 
host. In addition to aiding in digestion, microbes benefit the host through the local synthesis of short-chain fatty 
acids (SCFAs), including butyrate, propionate, and acetate. SCFAs can reach luminal concentrations of 130 mM in 
the proximal colon and function as the primary metabolic fuel for intestinal epithelial cells 20. Reduced production of 
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SCFA-producing microbial species has been associated with colonic disease, including inflammatory bowel disease  
(IBD)21-23. The low-O2 (anaerobic) conditions that enable SCFA production place unusual metabolic demands on the 
colonic epithelium24 and are enhanced during inflammation25 It is particularly notable that the microbiota is a key 
regulator of redox potential in the mucosa26.  
 Aside from homeostatic and regulatory functions, ROS are well characterized to be produced and 
contribute to disease processes – acutely during ischemic damage, tissue injury and repair and chronically in 
inflammatory conditions such as ulcerative colitis, Crohn’s disease and colorectal associated cancer. This Review 
will provide an overview of redox reactions in the gastrointestinal tract and describe how various sources of redox-
sensitive pathways contribute to the function of the healthy and diseased mammalian intestine. We will also discuss 
exciting new findings that highlight the contributions that different intensities of redox signaling in microbial-host 
crosstalk have towards maintaining homeostasis or facilitating disease processes within the gastrointestinal tract. 
  
[H1] Redox signaling in the gut  
[H2] Reactive oxygen species generation 
 
Reactive oxygen species (ROS) constitute a major group of potent antimicrobial mediators and redox signaling 
factors. Both the gastrointestinal mucosa and associated immune cells represent sources of free radicals, which are 
defined as chemical species with one or more unpaired electrons in the outermost orbital shell, making them 
chemically reactive 27. The reduction and oxidation (redox) state of the gastrointestinal tract is contingent on the 
balance of antioxidants (for example, heme oxygenase or glutathione, a tripeptide consisting of glutamate, cysteine 
and glycine) and oxidants (for example, free radicals, reactive oxygen and nitrogen species). When an imbalance in 
redox state occurs, owing either to increased oxidants or insufficient neutralizing antioxidants, the tissue experiences 
oxidative stress or nitrosative stress28. In the gastrointestinal tract, a variety of reactive oxygen radicals including 
superoxide (O2.-) and hydroxyl (.OH) and non-radicals including hypochlorous acid (HOCl) and hydrogen peroxide 
(H2O2) are generated epithelia, endothelia and innate immune cells to implement mucosal defense 29 (Figure 1). 
Tissue homeostasis is influenced in a variety of ways by the redox state of the tissue, including modulation of 
signal-transduction pathways (e.g. HIF, NF-kB, Nrf2) 30 that elicit adaptive gene expression to minimize bystander 
tissue damage. Through reduction of disulfide bonds found in many gut peptides, redox state can also modulate the 
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activity of antimicrobial peptides involved in mucosal defense and cytokine secretion31. Of particular significance is 
the redox state of the ubiquitously-expressed human beta defensin-1 (hBD-1). In the oxidized state, hBD-1 exhibits 
a limited antimicrobial activity; however, following reduction of the disulfide bridges, hBD-1 alters conformation 
and displays an enhanced antimicrobial efficacy 32. Indeed findings from the Wehkamp group demonstrate that the 
reduced form of hBD-1 is capable of forming net-like structures around bacteria to limit bacteria invasion 33. 
 
[H2] Reactive nitrogen species 
  
Nitric oxide (NO) is a short-lived, lipophilic and freely diffusible signaling molecule synthesized by mammalian 
cells with a broad spectrum of activities including regulation of blood flow, immune reactions and smooth muscle 
contraction 34. NO is generated by the nitric oxide synthase (NOS) enzymes, which convert L-arginine to L-
citrulline, liberating NO as a by-product 35. In the gastrointestinal tract, NO functions as an inhibitory nonadrenergic 
noncholinerigic neurotransmitter and smooth muscle cell relaxant via activation of guanylate cyclase 36,37. To date, 
three isoforms of NOS have been cloned: neuronal NOS (nNOS; NOS1), endothelial NOS (eNOS; NOS3) and 
inducible NOS (iNOS; NOS2) 38-40. Interaction of O2.- with nitric oxide (NO) leads to the formation of peroxynitrite 
(ONOO-) 41. Further reactivity of peroxynitrite leads to the generation of various other NO-derived mediators termed 
reactive nitrogen species (RNS), including the reactive radical compounds nitrogen dioxide (NO2.) and hydroxyl 
radical (HO.), and nonradical dinitrogen trioxide (N2O3) 41. ONOO- together with RNS are in turn responsible for 
nitrosylation of protein tyrosine residues, mitochondrial energy depletion, lipid peroxidation and induction of DNA 
strand breaks 42. Nitrosative and oxidative stress have been implicated in a plethora of disease states, including 
conditions that affect the gastrointestinal tract (namely ischemia reperfusion injury and inflammatory bowel 
diseases) 30.  
 [H2] Sources of reactive oxygen species 
 
Both exogenous and endogenous sources of ROS contribute to the overall redox state of the gastrointestinal tract. 
Endogenous sources contributing to ROS generation include the mitochondrial respiratory chain 43, enzymes within 
the mucosal epithelia and submucosal lamina propria fibroblasts and myofibroblasts such as NADPH oxidases, 
xanthine oxidase and immune-expressed cyclooxygenases, lipoxygenases and myeloperoxidase28. Exogenous or 
environmental sources of ROS can also trigger oxidative stress, such as ionizing and nonionizing radiation, 
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chemotherapeutics, xenobiotics, heavy metals and drugs 44,45. Generation of ROS by cancer chemotherapeutic agents 
is a major contributor to the toxic side effects associated with these compounds 45. Cigarette smoke comprises 
>7,000 chemical compounds and oxidative agents, containing >1014 free radicals per inhalation 46. Tobacco use is 
known to modulate gastrointestinal diseases and active smokers display an increased risk for colorectal cancer 47 and 
increased severity of Crohn’s disease 48. For reasons that are not completely clear, tobacco smoke appears to confer 
a somewhat protective influence to patients with ulcerative colitis  49. 
[H1] Mitochondrial metabolism and ROS  
 
 While mitochondrial ROS (mtROS) are renowned for causing cellular damage (for example, during ischemia-
reperfusion injury 50 ), mtROS are now thought to contribute to healthy cellular function in terms of oxygen sensing, 
as well as disease 51. Physiological production of mtROS occurs during oxidative phosphorylation and generation of 
high-energy adenosine triphosphate (ATP). The tricarboxylic acid cycle is tightly regulated; however, <2% of O2 
consumption results in conversion to O2.-, whereby electrons leak out from the mitochondrial electron transport 
chain (ETC) and are aberrantly transferred to molecular oxygen 52. Mitochondrial ETC complexes are capable of 
generating ROS at various sites. Complex I and II release O2.- into the mitochondrial matrix 53, whereas manganese 
superoxide dismutase converts it to H2O2. Complex III can produce O2.- within the inner membrane, but it is ejected 
into the intermembrane space, due to a large transmembrane electrical gradient 54. If O2.- generated by the 
mitochondrial ETC is not efficiently converted to H2O2, nitric oxide radicals  produce peroxynitrite (ONOO-), 
leading to subsequent irreversible nitration of proteins and enzyme inactivation42.  
 Cellular stressors such as ROS and hypoxia are hallmarks of pathogen invasion, but also reflect the local 
environmental fluctuations experienced by intestinal epithelial cells during active inflammation or infection 6. There 
is interest in autophagy as a substantial contributor to intestinal disease mechanisms, especially IBD55. Autophagy 
represents a primordial cellular degradation pathway that facilitates cell survival under conditions of metabolic 
stress, in which cytoplasmic targets are engulfed by a double-membrane vacuole <1 micrometer in diameter termed 
the autophagosome that is subsequently fused with lysosomes for hydrolase-mediated digestion56. Considerable 
overlap exists between cellular stimuli for selective autophagy of damaged organelles (self) and invading 
microorganisms (non-self)57. Mitophagy is a particular type of autophagy, whereby mitochondria are specifically 
targeted for autophagic lysosomal degradation 58. Mitophagy is a highly regulated event and some studies indicate 
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that the mitochondrial 18 kDa translocator protein (TSPO) is central to both regulation of mitochondrial ROS 
generation and the induction of mitophagy59. Interestingly, the overexpression of TSPO in animal models of IBD 
have revealed that TSPO localizes with epithelial mitochondria 60. Considering the Endosymbiotic Theory, which 
postulates the ancient common origin between mitochondria and proteobacteria 61, it is curious to speculate how a 
pathway such as autophagy evolved to ignore functionally competent mitochondria and their proteobacterial 
ancestors, but be triggered by invasive pathogenic organisms or damaged mitochondria.  
 
[H2] H2O2 as a signaling molecule 
 
Oxygen radicals have a limited range of effect due to their short-lived and highly reactive nature62 Specialized 
enzymes, such as superoxide dismutases, convert oxygen radicals to the more stable and readily diffusible H2O2 
(Figure 1). Due to its reduced reactivity, increased half-life and ability to induce reversible protein modification, 
H2O2 can act as a signaling molecule in its own right 62. H2O2 has been demonstrated to oxidize cysteinyl thiol, 
induce disulphide bond formation and mediate glutathionylation of cysteine or sulphoxidation of methionine 
residues in numerous proteins. Such modifications can alter protein activity (increased or decreased) but also 
represents an important antioxidant defense mechanism 63 . In this Review we shall focus primarily on the role of 
H2O2 in mucosal-microbiota crosstalk, but it is noteworthy that other redox signaling mechanisms (e.g. 
nitrosylation), provide important signaling cues during host-bacterial interactions64.  
 
[H2] Antioxidant pathways 
 
Regulators of the antioxidant response include enzymes that catalyze and neutralize ROS, ensuring their potent 
activity is short-lived to minimize collateral damage to the host tissue. Within the gastrointestinal mucosa 
antioxidant defense systems, superoxide dismutases and glutathione peroxidase enzymes act as detoxification 
pathways for ROS. Superoxide dismutases (SOD) are metal ion cofactor-requiring enzymes that catalyze the 
dismutation (i.e. partitioning) of superoxide anions to H2O2 and oxygen 65. In humans there are three SOD isoforms: 
mitochondrial SOD (manganese-requiring), cytosolic and extracellular SOD (both requiring copper and zinc). 
Mucosal injury mediated by H2O2 can be mitigated by SOD activity in the gastrointestinal tract 66. Indeed increased 
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SOD activity is associated with mucosal healing of human gastric ulcers, whereas reduced SOD correlates with 
increased ulcer severity 67.  
 Conversion of glutathione into oxidized glutathione is performed by the glutathione peroxidase (GPX) 
enzyme system. In the process, H2O2 is enzymatically reduced to H2O 68. Within the human gastrointestinal tract, 
expression of GPX1 is ubiquitous but GPX2 is expressed specifically in epithelial cells 69 and is postulated to protect 
the mucosa from transporting luminal-derived  lipid hydroperoxides 70. Deletion of either Gpx1 or Gpx2 in mice had 
no phenotypic effect, but double-knockout mice develop spontaneous colitis 71. Dismutation of H2O2 can also be 
achieved by the enzyme catalase, which converts to 2H2O2 to 2H2O and O2 72. Peroxiredoxins represent another 
important family of thiol-specific antioxidant enzymes, designated PRDX1-6 and encoded by 6 different genes 
(reviewed extensively elsewhere 73). It is notable that there little redundancy exists within this family of proteins, 
where the loss of individual peroxiredoxin lead to numerous pathologies, including haematological disorders, tumors 
and increased susceptibility to diseases associated with oxidative stress 74. Somewhat surprisingly, mice deficient in 
PRDX2 and PRDX6 are protected from acute colitis  75,76.  While not completely clear, the mechanism of PRDX2-
mediated protection may involve ROS-dependent stability of FoxO1 and Foxp3 regulatory T cell development.  
 A crucial regulator of the antioxidant response is the NF-E2 related factor 2 (Nrf2) transcription factor. 
Nrf2 forms heterodimers with small Maf proteins and binds to antioxidant response elements in the regulatory 
region of promoters of cytoprotective and antioxidant enzymes, regulating de novo transcription. Kelch-like ECH-
associated protein 1 (Keap1), an adaptor subunit of Cullin 3 ubiquitin ligase, regulates the function of Nrf2 by acting 
as a redox sensor (reviewed 77). Thus, antioxidant pathways provide an equally important and significant balance to 
redox signaling responses in the gastrointestinal tract.  
[H1] Redox signaling in the immune system  
 
Active mucosal inflammation can rapidly deplete both nutrients and oxygen in the immediate environment. For 
example, when activated, PMN can increase their O2 demand by as much as 50-fold in the generation of ROS (the 
so called respiratory burst mediated by NADPH oxidase) necessary to kill microbes following phagocytosis 78. By 
contrast, proliferating T cells only moderately increase oxygen consumption during immune responses 79. Mucosal 
tissues possess both the ability to generate and attenuate redox signals; however, it is widely accepted that in the 
context of inflammation, the majority of radicals and reactive species are derived predominantly from the activity of 
10 
 
resident and infiltrating immune cells, in particular, professional phagocytes of the innate immune system, such as 
neutrophils, monocytes, macrophages, dendritic cells and mast cells.   
 
[H2] NADPH oxidases and ROS 
 
The plasma-membrane NADPH oxidase (NOX) family of enzymes are a group of paralogous enzymes, sharing 
common subunits. The complexes are made up of both membrane and cytosolic protein subunits that, upon 
activation, organize in the membrane to catalyze the conversion of molecular oxygen to superoxide anion80. The 
spectrum of NOX-mediated activity ranges from potent bactericidal capacity of professional phagocytes to critical 
intracellular signaling in numerous cell types.  
In terms of enzymatic capacity, the redox factors produced by phagocyte oxidases and peroxidases 
exemplify the extreme end of the redox spectrum. In addition to phagocytes expressing NOX2, fibroblasts, 
endothelial and epithelial cells all express enzymes that permit generation of ROS, including NOX1, NOX3, NOX4, 
NOX5, DUOX1 and DUOX2 81 (Figure 1). While DUOX2 and NOX4 are expressed throughout the human 
gastrointestinal tract, NOX1 expression is highest in the distal colon where it is restricted to the cytosol, presumably 
to transduce intracellular signaling 29. By comparison, DUOX2 is expressed on the apical surface of epithelia, 
ostensibly enabling luminal secretion of ROS 82. Others have examined the influence of NOX1or DUOX2-derived 
ROS on Campylobacter jejuni infection and discovered that ROS impaired bacterial capsule formation and virulence 
by altering C. jejuni gene expression 83. 
  
[H2] ROS and innate immunity  
 
Innate immune cells, including neutrophils, macrophages and dendritic cells represent the front-line of immune 
surveillance and defense and generation of ROS is a crucial microbicidal mechanism used by these cells. Activation 
of the NADPH oxidase complex in innate immune cells elicits a rapid and potent respiratory burst 84. Defects in 
phagocyte NADPH oxidase function, such as in patients with chronic granulomatous disease (CGD), lead to 
leukocytes capable of phagocytosing but with impaired bacterial clearance 85. The hallmark of CGD is recurrent 
bacterial and fungal infections. Typically ~40% of patients with CGD develop IBD-like symptoms 86.  
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Following their recruitment to sites of inflammation, monocytes can polarize into either ‘classically 
activated’ ( M1) or ‘alternatively activated’ (M2) macrophages, depending on the redox state and cytokine milieu of 
the mucosa87 (Figure 2). Typically, TNFα and IFNγ are accepted to elicit an M1 phenotype and T helper type 2 
cytokines result in M2 polarization; however, it is also apparent that macrophage phenotypes can display mixed 
phenotypes 88. These differentially polarized macrophages exhibit a spectrum of functionalities. The M1 phenotype 
is regarded as pro-inflammatory and characterized by expression of iNOS and, consequently, are an important 
source of RNS89. M2 macrophages are thought to demonstrate a range of activities ranging from wound healing 
(release of TGF-β) to suppressing T-cell function 11. Expression of the enzyme Arginase 1 by M2 macrophages 
depletes L-arginine, resulting in a down-regulation of the T cell receptor (TCR) ζ chain 90, impairing T lymphocyte 
function and resulting in immunosuppression. Aside from suppressing T cell function, ROS also contribute to 
regulatory T cell polarization and function91,92. The exact molecular mechanisms of how RSO influence regulatory T 
cell function have yet to be elucidated.  Taken together, the net influence of ROS in macrophage polarization might 
promote a state of immune tolerance as it relates to regulation of T cell function. 
 [H1] Host–microbial interactions and ROS  
 
The mammalian large intestine plays host to trillions of bacteria, viruses and fungi, collectively termed the 
microbiota. A finely balanced mutualism exists within the intestinal mucosa, in which microorganisms, essential for 
host health, might also initiate and perpetuate mucosal disease 93. The epithelium that lies juxtaposed to the mucosal 
immune system serves as a selective conduit between the host and microbial world. Recognizing that both the host 
and the gut microbiota (both commensals and pathogens) can generate a variety of ROS, the contribution of redox 
signaling to such interactions has emerged as a critical interface to host–microbe interactions in the gut.  
 
[H2] ROS and pathogen niche expansion 
 
Similar to resident gut microorganisms, opportunistic pathogens also use redox reactions to subvert host defenses 
and establish a niche. One of the most studied in this regard is the invasive enteric pathogen Salmonella enterica 
serovar Typhimurium (S. Typhimurium). This pathogen is associated with acute gastrointestinal inflammation and 
diarrhea, and elicits neutrophil chemotaxis into the mucosa94. Invasion is achieved through two type III secretion 
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systems that facilitate S. Typhimurium to enter and persist inside intestinal epithelial cells and mucosal 
macrophages94. Prior to invasion, S. Typhimurium must out-compete the resident gut microbiota. Some studies 
indicate that inflammation amplifies proliferation of luminal S. Typhimurium, enabling it to overgrow other 
microorganisms95. In one report, the Bäumler group demonstrated that inflammation-induced intestinal ROS reacted 
with luminal thiosulfate to form a new respiratory electron acceptor, tetrathionate 96. Moreover, S. Typhimurium 
express genes to enable utilization of tetrathionate as an electron acceptor that permits the pathogen to use 
respiration to outcompete fermenting microorganisms and establish a niche 96. The authors subsequently 
demonstrated that this tetrathionate-enabled respiration provided another growth advantage to S. Typhimurium, 
permitting the utilization of epithelial-derived ethanolamine under anaerobic conditions 97. 
 
[H2] ROS and pathogen niche restriction 
 
The role of H2O2 secretion into the lumen of the gut is poorly understood, but several roles have been proposed. 
Some studies suggest a pro-inflammatory function for DUOX-derived H2O2, acting as a chemotactic signal for 
neutrophils in a zebrafish wound-healing model 98 and a murine allergic airway model 99. Other findings suggest 
apical secretion of H2O2 into the lumen of the gut is implicated in restricting Helicobacter felis colonization in mice 
through increased bacterial oxidative stress 100. Another study examined the influence of NOX1 or DUOX2-derived 
ROS on Campylobacter jejuni infection and discovered that ROS impaired bacterial capsule formation and virulence 
by altering C. jejuni gene expression 83. During Citrobacter rodentium infection in wild type mice, the Knaus group 
discovered that NOX1 regulates DUOX2 expression in the mucosal epithelium, with a resultant decrease in both 
superoxide and H2O2 production 101. An unexpected but intriguing finding from this study was that ablation of 
epithelial-derived ROS, using an epithelial-restricted Cyba-deficient mouse (absence of the obligatory NOX 
dimerization partner), led to protection from C. rodentium-induced colitis. The authors attribute their findings to an 
altered gut microbiota with an expansion in H2O2-producing lactobacilli, which exert an antimicrobial effect by 
release of urease, lactic acid and H2O2 102. Pircalabioru et al. demonstrated through the use of catalase to degrade  
H2O2 derived from lactobacilli was responsible for attenuating C. rodentium virulence factors 101. Other findings to 
support H2O2 exerting an antimicrobial function include disruption of microbial intracellular signaling, which affects 
antioxidant defense and polysaccharide biosynthesis 103. In the human body, L-amino acids are essential for protein 
synthesis; however, D-amino acids function in necessary non-ribosome-based roles 104. Bacteria synthesize and 
13 
 
secrete distinct D-amino acids into the lumen of the colon 105 and the Waldor group demonstrated that microbiota-
derived D-amino acids upregulate expression of the host epithelial-expressed enzyme, D-amino acid oxidase (DAO), 
which is secreted into lumen. Oxidative deamination of D-amino acids by DAO yields H2O2 as a by-product and 
protects from Vibrio cholerae pathogenicity 106. 
 
[H2] Resident gut microbiota and ROS  
 
A number of studies from the Neish group have highlighted a beneficial influence of probiotic and resident 
microorganisms in eliciting ROS generation from epithelial sources107 (Figure 1). In both Drosophila melanogaster 
and mouse models, Lactobacilli species were shown to induce epithelial-derived ROS via NOX1 activity, which 
stimulated epithelial proliferation 108. Subsequent studies by this group demonstrated dependence on the redox-
sensitive transcription factor NRF2 through mechanisms that involve cytoprotection and decreased epithelial 
apoptosis  109. Further studies from this group and others have elegantly implicated a role for epithelial-expressed 
formyl peptide receptor (FPR), responding to microbial N-formyl-methionine-leucine-phenylalanine (fMLF), in 
intestinal epithelial wound healing110,111. Further studies have revealed that this wound healing response occurs 
through oxidative inactivation of the regulatory phosphatases PTEN and PTP-PEST, with associated  activation of 
focal adhesion kinase (FAK) and paxillin112. Central to such mucosal wound healing responses appears to be the 
regulation of epithelial cell migration. For example, redox sensitive tyrosine phosphatases (for example, SHP2 and 
LMW-PTP) that are expressed at the edge of wounded epithelial monolayers are critical to the organization of focal 
adhesions that organize epithelial migration and wound closure 113. Loss and gain of function studies have shown 
that both ANXA1 and NOX1-null mice show substantial deficits in mucosal wound healing responses and that 
ANXA1 delivery promotes would healing 112. These investigators have also demonstrated that FPR/NOX2-mediated 
ROS generation at local intestinal tissue sites select for mucus-resident microorganisms, including Akkermansia 
muciniphilia, that accelerate epithelial wound-healing, in an intestinal epithelial NOX1-dependent fashion 114  
[H1] Consequences of redox signaling  
 
Redox-sensitive signaling pathways are often limited by the availability of extracellular and intracellular oxygen 
115Despite this understanding, ROS generation can occur at surprisingly low oxygen tensions. The neutrophil 
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NADPH oxidase, for example, is fully functional at ambient oxygen concentrations as low as 1% 78. Such 
observations highlight the importance of discriminating oxygen and ROS diffusion within the tissue 
microenvironment, as well as the variability of oxygen availability within individual tissues. These differences often 
determine endpoint tissue function and define the adaptability of tissues to hypoxic stress 116.  
 
[H2] Colonic tissue oxygen metabolism  
 
The partial pressure of oxygen (pO2) at sea level is ~145 mmHg and the alveoli of healthy lungs experience a pO2 of 
~110 mmHg 117. The lumen of the colon is virtually anoxic, mainly due to the microbial biomass118, and colonic 
epithelia adjacent to the lumen experience and withstand a pO2 <10 mmHg119. Thus, it might be surprising to 
discover that epithelial stem cells at the crypt base are highly oxygenated (experiencing a partial pressure of 
~100mmHg) 93. Such differences are compounded by epithelial metabolism and the arrangement of the 
microvasculature network into counter-current blood flow dynamics within each villous structure 93. Epithelia 
adjacent to the lumen effectively exist in a state of ‘physiological hypoxia’ 120 and are uniquely susceptible to 
changes in redox state. Experimental use of oxygen-sensitive nitroimidazole compounds has enabled visualization of 
hypoxia in these tissues both basally and during inflammation 121. It is notable that these dyes are neither dependent 
on redox enzymes nor changed by the NADH and NADPH levels 122. This technology, coupled with 
immunostaining, has been used to visually reflect the oxygenation of larger solid tumors in mice  123 and might even 
be a more reliable marker than staining for HIF-1, as it is retained in chronically hypoxic cells 124 Such physiological 
hypoxia (Figure 1) is reversible by oxygenation of the colonic lumen (for example,  using oxygenated 
perfluorodecalin) 125.  
  Various factors aside from limited O2 availability influence the activity of the PHD enzymes and HIF 
stabilization. Among them, H2O2 has been demonstrated to stabilize HIF via inhibition of the PHD2 enzyme 126. 
Transcriptional activity of the HIF transcription factors regulates the genes involved in adaptive responses to 
hypoxia, the most widely acknowledged include angiogenesis- and glycolysis-related genes (e.g. VEGF, iNOS, 
GLUT1, PGK1). Less well characterized, but rapidly increasing in number, are genes with associated mucosal-
protective functions that enable colonic epithelial cells to restore impaired barrier function (e.g. ITF, MUC3, 
CLDN1, MDR1) 119. Original studies using genetic loss and gain of intestinal epithelial Hif1a expression in mice 
revealed a protective role for HIF in chemically-induced colitis models that corresponded to mucosal barrier 
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protection 121. Studies with cultured intestinal epithelial cells exposed to conditions that activate HIF have identified 
the regulation of a number of barrier-related protective genes 127 that have now been validated in animal models of 
colitis 121,128-132 and in human-derived colonic tissue 8,133-135. The intestinal epithelial barrier proteins encoded by HIF 
target genes include those that localize to the apical surface of polarized epithelia, including mucins and mucin 
modifiers (for example, intestinal trefoil factor), tight junction proteins (claudin-1), antimicrobial peptides and 
proteins important for xenobiotic clearance119. Each of these components are direct transcriptional targets of HIF and 
contribute fundamentally to the 3D intestinal tissue architecture that forms an intact barrier during homeostasis. 
 
[H2] Induction of epithelial HIF  
 
Following recruitment of immune cells to the mucosa, for instance following induction of experimental colitis, 
hypoxia extends deeper into tissue 121, a phenomenon termed inflammatory hypoxia 136 (Figure 1). One study by 
Campbell et al., 8 demonstrated that during experimental murine colitis, neutrophil influx was primarily responsible 
for inflammatory hypoxia. By use of a combination of neutrophil antibody depletion, hypoxia-reporter mice and 
NOX2 deficient (Gp91phox-/-) mice, the authors demonstrated that functional NOX2 not only disseminated mucosal 
hypoxia but stabilized HIF within the intestinal epithelium. This HIF-signature within the epithelium resulted in an 
adaptive transcriptional response, that the authors coined ‘transcriptional imprinting’ 8. Biopsy samples from 
patients with ulcerative colitis with evidence of crypt abscess formation – a pathological hallmark with 
transmigrated neutrophils within the lumen of the crypt – revealed induction of HIF (monitored by increases in the 
HIF-target gene GLUT1). However, it is unclear from these studies if HIF stabilization is due to depletion of oxygen 
or generation of superoxide or H2O2, as all are capable of inhibiting the PHD enzymes 25,137.  
 Another means to stabilize HIF by inhibition of PHD enzyme function is via depletion of another crucial 
cofactor, iron. Some findings indicate that certain microorganisms, such as Klebsiella pneumoniae and 
Pseudomonas aeruginosa can stabilize HIF in lung epithelia, via secretion of low-molecular-weight, high-affinity 
iron chelators, termed siderophores 138,139. Presumably, these factors function to chelate iron bound within the active 
site of the PHD enzymes, though this has not been shown conclusively. Fermenting microbiota have also been 
shown to stabilize HIF in the colon, via short chain fatty acid release, particularly via butyrate production 140. 
Butyrate is used as the preferred enterocyte fuel source, oxidizing butyrate to CO2 141. The net effect is epithelial 
hypoxia due to increased oxygen consumption, likely resulting in PHD enzyme inhibition to facilitate HIF 
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stabilization 140. Indeed, a study from the Bäumler group in 2016 demonstrated that streptomycin-treated mice 
exhibited a decline in butyrate-producing Clostridia, which led to increased oxygenation of the mucosal epithelium, 
enabling enhanced Salmonella expansion 142.  
 
[H2] Inflammasome activation  
 
The NOD-like receptor family, pyrin domain-containing protein 3 (NLRP3) inflammasome is an intracellular 
multiprotein complex involved in perceived cellular danger response 143. Pathogen-associated molecular patterns 
(PAMPs) and host-derived danger-associated molecular patterns (DAMPs) can trigger inflammasome activation 144. 
Stimulation of NLRP3 leads to assembly of this inflammasome complex and, ultimately, to caspase-1 activation and 
downstream cleavage of pro-inflammatory cytokines IL-1β and IL-18 145. The role of IL-1β is widely studied in 
autoimmune diseases; however, in gastrointestinal inflammation its involvement is not fully understood. Studies 
using chronic mouse models of colitis have demonstrated a role of IL-1β in accumulation of IL-17A secreting CD4+ 
T helper type 17 cells 146. One study in 2017 by Neudecker et al., implicated CCR2+ monocytes and NLRP3 activity 
leading to IL-1β production in the pathogenesis of acute colitis in mice147. Surprisingly, mice lacking NLRP3 are 
hypersensitive to experimental colitis, displaying exacerbated immune infiltration and epithelial damage, primarily 
due to a loss of IL-18 148. Despite the intense interest in the field, relatively little is known about how the NLRP3 
inflammasome is regulated at a molecular level. Some studies suggest that autophagy can negatively regulate the 
NLRP3 inflammasome 149. Conversely, activation of ROS, ostensibly by NADPH oxidases 150 has been shown to 
stimulate the NLRP3 inflammasome. However, patients with CGD with NADPH-deficient macrophages display 
normal inflammasome activation in several studies 151,152, implicating other stimuli aside from NADPH-oxidase-
derived ROS. Another abundant source of cellular ROS are mitochondria, which release ROS in response to 
elevated metabolism, hypoxia or membrane damage 153. The Tschopp group demonstrated that inhibition of 
mitophagy (encapsulation and degradation of old or damaged mitochondria via cellular autophagic machinery) 
results in the accumulation of damaged ROS-generating mitochondria, which leads to NLRP3 inflammasome 
activation 154. The authors subsequently demonstrated that both ROS generation and NLRP3 activation were 
suppressed when mitochondrial activity was disrupted by blockade of the voltage-dependent anion channel. These 
findings suggest that the NLRP3 inflammasome can perceive mitochondrial dysfunction 154. 
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[H2] Goblet cell mucus secretion  
 
Goblet cells are specialized epithelial cells that protect the barrier from microbial invasion by secretion of a mucus 
hydrogel 155. The principal components of mucus are large mucin peptides arranged in polymeric structures. 
Following translation, mucins undergo extensive N-linked and O-linked glycosylation modifications and are 
packaged into vesicles 4. Goblet cell-derived glycosylated mucins provide a major carbon source for the gut 
microbiota (reviewed elsewhere 5). Interest has centered on understanding the regulation of mucin packaging and 
secretion at baseline and in response to microorgansims detection 156, which has led to the suggestion that goblet 
cells actually represent an unappreciated and distinct innate immune cell 4,157. Another secretory epithelial lineage, 
Paneth cells — which are tasked with antimicrobial peptide secretion and defense of the intestinal stem cell niche — 
rely on autophagy to organize secretory granules 158. By contrast, autophagy compromised goblet cells displayed 
normal mucin packaging into granules 159. However, a combination of autophagy and NADPH oxidase-derived ROS 
were found to be essential for mucin release by goblet cells (Figure 2). Patel et al. demonstrated that amphisome-like 
vesicles form in goblet cells following autophagosome and endosome fusion and these specialized organelles 
regulate mucin secretion 159. It was subsequently demonstrated that the NLRP6 inflammasome is crucial for 
promoting goblet cell mucin release in response to proximity with microorganisms 160. In 2016, the Hansson group 
proposed the existence of a ‘sentinel’ goblet cell 161 based on proximity to the crypt entrance. This sentinel goblet 
cell non-specifically endocytoses and responds to TLR ligands, stimulating NOX1or DUOX2-dependent ROS 
production, through downstream activation of the NLRP6 inflammasome. Moreover, via intercellular gap junctions, 
signals are transduced down the crypt axis to elicit mucin secretion from neighboring goblet cells 161.  
 Secretion of additional mucins in response to detection of microbial proximity is obviously one approach to 
repel a microbial onslaught, but goblet cell hyperplasia represents an alternative mechanism. As mucus erosion and 
goblet cell depletion are pathological hallmarks of ulcerative colitis162, repletion of both goblet cells and their mucin 
granule contents is necessary for epithelial barrier restitution (Figure 3). As mentioned previously, IL-18 secretion is 
stimulated by ROS-mediated inflammasome activation145,  where some findings reveal distinct and opposing roles 
for IL-18 and IL-22 signaling in regulating goblet cell homeostasis. For example, Flavell and colleagues 
demonstrated using various intestinal epithelial-specific knockout mice to target IL-18 signaling, that excess IL-18 
promotes goblet cell depletion and colitis. Moreover, IL-18 appears to suppress goblet cell differentiation markers 
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163. Contrastingly, immune cell-derived IL-22 has well-recognized protective mucosal effects via promoting stem 
cell differentiation, mucin synthesis (mucin 2), antimicrobial peptide (RegIIIγ) and goblet cell function (Fut 2 
expression) 164-166. The recently characterized type-3 innate lymphoid cells (ILC3) are the major source of IL-22 
within the intestinal mucosa 167. In fact, during Toxoplasma gondii infection, ILCs and T cells required epithelial-
derived inflammasome-processed IL-18 in order to release IL-22 168. Thus, a combination of redox signaling, 
inflammasome activity and immune crosstalk might hold the key to homeostasis between IL-18 and IL-22 signaling 
and indeed mucosal-microbiota homeostasis. Moreover, IL-1β can both induce activation of ILC3 and contribute to 
plasticity (in concert with other factors, including retinoic acid) and reprograming of ILC1 and ex-ILC3 to ILC3s 169. 
 
[H1] Redox signaling in intestinal disorders 
  
 [H2] Ischemia–reperfusion injury 
 
Ischemia is defined as insufficient blood flow to tissues, resulting in disruption of cell function and ultimately 
necrosis. A variety of tissue insults can lead to intestinal ischemia, including trauma, stroke and atherosclerosis, and 
reperfusion (restitution of blood supply) following ischemia can result in aggravated tissue damage. The intestine is 
particularly sensitive to ischemia–reperfusion injury (I/RI) 170. Ischemia rapidly induces expression of 
cyclooxygenase (COX) and accumulation of cells expressing lipoxygenase enzymes, which are responsible for 
generating pro-inflammatory eicosanoids from membrane liberated arachidonic acid, such as prostaglandins and 
leukotrienes171. Constitutively expressed COX1 and the inducible isoform COX2 are responsible for catalyzing the 
conversion of arachidonic acid to prostaglandins 172. The primary prostaglandin studied in this context is 
prostaglandin E2 (PGE2) 173, which elicits a bifunctional influence on the intestinal mucosa, promoting injury via 
vasodilatory influences on the endothelium but simultaneously conferring cytoprotection to the intestinal epithelium 
174. Infiltrating leukocytes expressing 5-lipoxygenase and 15-lipoxygenase leukotriene B4 (LTB4), produced by 
endothelial cells, a potent chemoattractant of neutrophils and facilitates neutrophil adhesion and degranulation 175. 
Following reperfusion, a necessary substrate (oxygen) becomes available to enable the de novo synthesis of an 
‘eicosanoid storm’, where is essence, bioactive lipids of the eicosanoid family become significantly amplified in 
their production 176. This combination of lipid-mediator and neutrophil accumulation in the tissue milieu results in 
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another consequence upon I/RI, namely lipid peroxidation177, the oxidative degradation of lipids that result in 
plasma membrane and organelle damage. ROS generated by reoxygenated neutrophils have long been recognized as 
instigators of lipid peroxidation in intestinal I/RI, resulting in barrier disruption50,135,170,177. Indeed, treatment with 
superoxide dismutase in a murine intestinal  I/RI model limits the contribution of ROS to both lipid peroxidation and 
mucosal permeability 177. Experimental strategies to circumvent the deleterious exaggerated inflammation and 
resultant tissue damage occurring in I/RI mostly hinge on reducing neutrophil recruitment signals and leukocyte 
activation 178. The anti-inflammatory influences of carbon monoxide, derived from endogenous heme oxygenase, 
might be a promising therapeutic strategy to attenuate damage from I/RI 179. Multiple lines of evidence have 
revealed that the activation of heme oxygenase effectively promotes cytoprotection and inhibits the pro-
inflammatory signatures elicited from multiple cell types during intestinal I/RI179. Strategies to induce heme 
oxygenase and carbon monoxide release are in development and include HO1 fusion proteins, small molecule heme 
oxygenase inducers, bilirubin, glutamine and inhaled carbon monoxide179.  
 
[H2] Ischemic preconditioning 
 
Aside from leukocyte-derived sources of ROS, the mucosa itself can contribute significantly to redox-mediated 
damage during intestinal ischemia. High concentrations of ATP are released extracellularly during ischemia, which 
are ultimately catabolized to hypoxanthine 180. Concomitantly, ischemic stress results in the conversion of xanthine 
dehydrogenase to xanthine oxide 181. Following tissue reperfusion, the combination of hypoxanthine, xanthine oxide 
and newly available molecular oxygen yields additional sources of tissue superoxide anion 182. Although some 
limited therapeutic success has arisen from scavenging ROS or targeting inflammatory mediators, one of the more 
promising strategies to reduce I/RI is ischemic preconditioning (or hypoxic preconditioning), whereby cells or 
tissues are exposed to brief and intermittent periods of non-lethal ischemia. Such treatments have been shown to 
protect organs that experience a major ischemic event, which is best studied in the heart.183. The mechanisms 
involved in ischaemic preconditioning are complex but ultimately result in reduced pro-inflammatory factors, 
decreased lipid peroxidation and elevated levels of natural antioxidants including glutathione, SOD and HO1184. 
Khoury et al. identified extracellular adenosine released by hypoxic preconditioned intestinal epithelia as the major 
anti-inflammatory factor responsible for hypoxic preconditioning 185. This protective role of adenosine in ischemic 
preconditioning corresponded with the inhibition of NF-kappaB via deneddylation (where NEDD8 is removed from 
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a conjugated protein) of cullin-1 (Cul1), a component of the proteasomal degradation pathway important in the 
activation of NF-kappaB186. It was shown that adenosine might regulate HIF through similar mechanisms; for 
example, a small molecule deneddylator of the cullin family proteins has become commercially available. This 
compound, MLN4924, is an adenosine monophosphate analog that functionally inhibits Nedd8 activating enzyme 
and results in the de-neddylation of Cul1 and Cul2187,188 and has proven to be a potent HIF stabilizer in cultured 
cells189. In this regard, HIF might function to promote tissue ischemic preconditioning, which has been shown in 
some studies13, and small molecule stabilizers of HIF (esp. PHD inhibitors) show promise in protection from 
damage associated with I/RI178.  
 Extracellular adenosine is derived from the enzymatic degradation of ATP via the action of surface 
apyrases (e.g. CD39) and ecto-5’-nucleotidase (CD73) 190. CD73 expression is increased on intestinal epithelia 
during hypoxia in a HIF-dependent manner, resulting in increased extracellular adenosine accumulation127. 
Moreover, HIF stabilization in hypoxia was also demonstrated to decrease expression of the equilibrative nucleoside 
transporter (ENT)1 and ENT2, resulting in reduced uptake of extracellular adenosine providing more available for 
extracellular signaling 191. Extracellular adenosine signals through activation of any of four surface G-protein 
coupled receptors. Activation of the A1AR or the A3AR results in decreased intracellular cAMP levels (Gαi-
coupled), whereas adenosine binding to the high affinity A2AAR or the low affinity A2BAR is associated with 
elevation of cAMP (Gαs-coupled) 192. The predominant receptor-mediated signaling associated with intestinal 
epithelial cells is A2BAR and the crystal structure of agonist and antagonist bound A2AAR has been resolved 193. 
The majority of evidence suggests that the induction of A2BAR by HIF translates to a strong anti-inflammatory 
phenotype in the intestinal mucosa, at least in part associated with barrier protection 194,195.  These studies have 
shown important protective roles for A2BAR in experimental colitis 194 and intestinal I/RI 196,197 that results in 
diminished inflammation 198. 
 A number of sources of nucleotides exist in inflamed and ischemic tissue. Many cell types actively release 
nucleotides, particularly in the form of ATP or ADP 192. Programmed cell death (apoptosis) is associated with the 
generation of large amounts of ATP during ischemia and inflammation. The ATP released by apoptotic cells has 
been demonstrated to function as a ‘find-me’ signal to promote phagocytic clearance during inflammatory resolution 
199. Other studies have shown that inflammatory cells, such as neutrophils, can release ATP in an active manner 
though connexin 43 hemichannels 200,201. Platelets release nucleotides at high concentration upon activation and are 
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also an important source of extracellular nucleotides during ischemia. In the intestinal mucosa, for example, platelets 
and neutrophils have been shown to co-migrate across the epithelium and into the lumen in the formation of crypt 
abscesses202. As originally described by Madara et al 203, this local generation of luminal nucleotides results in 
adenosine-mediated activation of electrogenic chloride secretion and associated water movement into the intestinal 
lumen. This fluid transport process provides an important flushing of the mucosal surface during ongoing 
inflammation.  
 
[H2] Role of ROS in IBD 
 
IBD includes ulcerative colitis and Crohn’s disease and is characterized as a chronic inflammatory condition of the 
gastrointestinal mucosae in susceptible individuals 55. Ulcerative colitis and Crohn’s disease exhibit distinct 
pathophysiology in terms of  effector immune functions. Common features of IBD include abdominal pain and 
diarrhoea, and that susceptibility to IBD is dictated by a combination of genetic, environmental and microbial risk 
factors 55. The microenvironment of active IBD lesions is considered to be strongly redox active, in which ROS are 
considered to play an important part in both inflammatory signaling and in bystander damage to surrounding 
tissue30.  
Does excessive ROS or insufficient ROS contribute to IBD? Evidence exists to support both excessive 
ROS or insufficient ROS as contributing to IBD. Considering the number and functional diversity of susceptibility 
genes in IBD identified by genome-wide association studies, it is likely that the answer to this question depends on 
the individual combination of etiological factors and not merely the diagnosis of ulcerative colitis versus Crohn’s 
disease. For instance, a study of 157 patients with CGD profiled IBD risk alleles among this cohort and concluded 
that defective superoxide generation in CGD is a major risk factor for IBD204.  
As alluded to earlier, the majority of patients with CGD develop IBD-like symptoms 86. A potentially 
confounding issue for research in this field is the mouse models used to address the roles of phagocyte-derived ROS 
versus mucosal sources. Campbell et al., 8 using a TNBS (2,4,6-trinitrobenzenesulfonic acid) model of colitis 
demonstrated that Nox2-/- mice develop substantially more severe colitis, reflected by increased weight loss, 
increased intestinal permeability and the failure to resolve ongoing inflammation compared to wild-type control 
mice. Conversely Bao et al., used the same mice in a dextran sulfate sodium (DSS) model of colitis and found no 
difference in weight loss or disease severity when compared to wild type controls 205. They concluded that less tissue 
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damage was associated with decreased oxidative burst, though no evidence was provided for increased ROS-
mediated damage. A possible explanation for the discrepancy between these studies is in the nature of the models 
used to ascertain the relative importance of phagocyte NOX. DSS models of colitis rely on denudation of epithelial 
cells, beginning with erosion of apical mucus, apoptosis of epithelia and resulting innate immune infiltrate206. Under 
such circumstances, it could be argued that phagocyte-derived ROS might not be contributing to denudation of 
colonic epithelia, therefore only genes or therapeutic intervention that influence epithelial viability or turnover will 
have an appreciable effect. By contrast, TNBS involves pre-sensitizing the host immune system to haptenized 
microbial antigens, with subsequent colonic exposure to the haptenizing agent206. DSS results in progressive tissue 
damage, extending proximally from the rectum, and incremental loss of body weight over the course of the 
experiment. TNBS-treated animals lose and regain weight rapidly over time and tend to exhibit skip lesions with 
relatively intact epithelia 206 Moreover, immune infiltrates and inflammatory mediators differ substantially between 
the models 206As such, DSS represents a wound model, whereas TNBS represents an acute-to-chronic inflammation 
and resolution model. Thus, it is conceivable that Nox2-/- mice do not exhibit enhanced mucosal wounding but 
rather, fail to resolve inflammatory insults. 
 Despite the dependence of IBD on genetic susceptibility and observed chronic adaptive immune responses, 
numerous aspects of disease progression are comparable between IBD and I/RI. For instance, proinflammatory 
mediators such as TNF-α and PGE2 are implicated in both I/RI and Crohn’s disease 50,207. Involvement of 
neutrophils, monocytes and leukocyte-derived ROS have been implicated in both ulcerative colitis and I/RI in the 
colon and intestine 50,208. Similarly, epithelial barrier disruption and enhanced microbial translocation are features of 
both IBD and I/RI 50,209. Studies have also suggested that shifts in the gut microbiome (dysbiosis) might contribute 
to both I/RI and IBD50,210. One important caveat to this understanding is the observation that antibody-mediated 
neutrophil depletion strategies in intestinal I/RI models do not appear to influence injury endpoints 211, whereas 
neutrophil depletion substantially enhances tissue damage in multiple colitis models 212. Another common feature 
between IBD and I/RI models, is accumulation of extracellular ATP in colitis models has been demonstrated to 
contribute to the inflammatory process, in part via stimulation of the P2X7 receptor 213. Also similar to ischemic 
preconditioning is that extracellular adenosine appears to confer mucosal protection during colitis, principally via 
A2BAR signaling. Indeed, murine models of whole body and conditional epithelial deletion of A2BAR results in 
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more severe DSS-induced colitis associated with decreased barrier function and diminished mucosal wound healing 
194,195. 
[H2] ROS-induced collateral tissue damage 
 
Substantial evidence exists that collateral tissue damage, the ‘bystander effect’, might result from increased 
oxidative stress associated with active intestinal inflammation 214. Implications of excessive ROS-mediated tissue 
damage in the gastrointestinal tract include alterations of absorptive function, barrier dysfunction and dysmotility 215. 
Numerous studies have, for example, indicated malabsorption of nutrients in the intestine following I/RI and in 
IBD216,217. Colonic epithelia, by contrast, are tasked predominantly with the reuptake of water from the faecal 
stream, so disruption to colonic absorption in IBD manifests as diarrhea 218. Extensive tissue damage from excessive 
ROS (for example, lipid peroxidation, protein chlorination of mucosal barrier proteins) and immune mediators such 
as TNF-α and IFN-γ increase mucosal permeability by modulating tight junction function 219 (Figure 3). One well-
documented mechanism of barrier disruption is via induction of so-called ‘leaky’ claudin tight junction proteins, 
such as claudin-2 and claudin-5 220. It is notable that increases in vascular permeability might precede increases in 
epithelial permeability during active mucosal inflammation (see Figure 3). Tolstanova, et al used four murine 
models of colitis to demonstrate that early endothelial damage resulted in perivascular edema and epithelial hypoxia, 
which contributed to the stabilization of HIF within the mucosa 221. Evidence for early ROS-mediated endothelial 
damage  were demonstrated at the level of electron microscopy and were consistent in genetic models of colitis, 
including IL-10-/- and Gα-i2 -/- 221. Finally, it is likely that gut motility is affected through redox-sensitive 
mechanisms. For example, Brown, et al showed that enteric neuron death during active colitis was mediated by 
nitric oxide derived from glial cells222 (Figure 3). Such neurotoxic activity was driven by nitric oxide influences on 
connexin-43 activity. Moreover, exposure of sub-mucosal smooth muscle cells to microbial lipopolysaccharide 
probably contributes to dysmotility through the generation of large amounts of ROS and RNS 223. Taken together, 
these studies implicate collateral tissue damage associated with oxidative stress in active intestinal inflammation. 
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[H1] Conclusions 
 
In conclusion, the gastrointestinal tract represents a particularly austere environment for redox-sensitive signaling. 
The combination of multiple sources of reactive oxygen or nitrogen species in the setting of trillions of 
microorganisms requires the presence of important gatekeeper mechanisms to avoid the potential chaos that could 
occur during active inflammation. Just as important is the need to maintain a well poised anti-microbial 
environment, in large part driven by epithelial and leukocyte-derived oxygen radicals. It is notable that the profound 
differences in local O2 tension within mucosal tissues and substantial increases in energy demand during 
inflammation provide a unique setting to understand tissue metabolism under stress. Of particular interest is the 
metabolic shift toward hypoxia and the associated stabilization of HIF-target pathways that associates with tissue 
barrier function, wound healing, autophagy and inflammation resolution. Redox signals derived from immune cells, 
parenchymal cells (epithelia, endothelial, fibroblasts) as well as the gut microbiota are coupled with the differing 
potencies, toxicities and halflives of the redox products produced locally that require tight control for tissue 
homeostasis. Studies in vitro and in vivo have provided new insights toward a better understanding of productive 
inflammatory responses and mechanisms that promote inflammatory resolution. Also relevant is the shift in tissue 
redox potential that mediate collateral tissue damage and endpoint organ function. A better understanding of the 
basic molecular signals, transcriptional programs and the environmental clues that regulate mucosal redox state (Box 
1) are likely to provide new insight toward the development of novel therapies for diseases such as IBD. 
 
[H1] Box 1: Knowledge gaps and future research directions 
- What host metabolic factors control to redox state threshold and under what conditions are they generated? 
- Could microbiota-derived factors that influence redox be enriched to benefit the host in health or during 
disease? 
- Does the low oxygen partial pressure environment of the gut provide an opportunity for drug targeting 
and/or drug delivery?  
- How does overall tissue redox state influence acute inflammatory resolution versus progression toward 
chronic inflammation?  
- Is innate immunity more amenable to therapeutic targeting than adaptive immunity, or vice versa?  
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- Is pharmacological stabilization of HIF (e.g., via PHD inhibition) a viable therapeutic option for mucosal 
disease?  
- What pharmacological approaches best mimic ischemic preconditioning and under what circumstances 
might this approach benefit the host? 
- For therapeutic targeting of redox pathways, how might we maximize the beneficial influence of redox 
signaling and minimize bystander tissue damage?  
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Figure 1: Host-microbial redox signaling during hypoxia.  
Enzymatic utilization of molecular oxygen within the intestinal mucosa facilitates redox signaling and results in both 
spatial and dynamic patterns of oxygen availability. a) In the healthy intestinal mucosa, a steep oxygen gradient 
exists between the highly vascularized mucosa and the anoxic lumen. Thus, cells within the crypt stem cell niche 
normally experience higher partial pressures of oxygen (~100mm Hg) compared with the luminal-effacing epithelia 
(<10mm Hg) which are known to normally experience hypoxia at homeostasis. This physiological hypoxia is 
experienced by epithelia adjacent to the lumen and results in stabilization of the HIF transcription factor. Gut 
microbiota secreting short chain fatty acids (SCFA), particularly butyrate, contribute to this physiological hypoxia 
through increased oxidative phosphorylation. Luminal redox signaling initiated by resident microorganisms 
releasing D-amino acids (D-aa) stimulates the epithelium to secrete D-amino acid oxidase (DAO) into the lumen, 
which is subsequently yields H2O2. Apical expression of epithelial DUOX2 probably results in luminal secretion of 
H2O2, which contributes to limiting opportunistic pathogen niche expansion. Probiotic Lactobacilli up-regulate 
epithelial NOX1 expression, which in turn induces DUOX2. Epithelial expressed NOX1 and DUOX2, utilizing 
microenvironmental oxygen, generate oxygen radicals to further contribute to luminal release of H2O2. b) During 
inflammatory hypoxia, infiltrating PMN and monocytes, expressing NOX2 generate superoxide (O2.-), resulting in 
inhibition of PHD enzymes and stabilization of HIF deep into the crypt. HIF transcriptional activity induces 
expression of barrier protective factors – antimicrobial peptides (AMPs), Mucin 3 (Muc3) and intestinal trefoil 
factor (TFF3). Certain opportunistic pathogens release siderophores, sequestering iron and inhibiting PHD enzymes. 
Sulfur metabolism of the mucosa can be hijacked by opportunistic pathogens – H2S is routinely detoxified to 
thiosulfate (S2O32-); however, high levels of reactive oxygen species within the mucosa can result in tetrathionate 
(S4O62-) generation, which can be utilized by Salmonella serotypes to provide a competitive advantage. 
 
 
Figure 2: Host redox–hypoxia crosstalk in the gastrointestinal mucosa.   
The two major sources of endogenous reactive oxygen species (ROS) within the intestinal epithelium originate from 
mitochondria and NOX1 or NOX4. a. In response to pathogen-associated molecular patterns (PAMPs) and danger-
associated molecular patterns (DAMPs), epithelia recruit and activate the Nox1/4 complex, stimulating superoxide 
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and hydrogen peroxide generation (sources of ROS). Both enzymatic and mitochondrial-derived ROS can trigger the 
activity of epithelial inflammasomes. b. In colonic epithelia, ROS-stimulated NLRP3 inflammasome assembly leads 
to IL-18 (and IL-1β) production.  Whereas excessive mature secreted IL-18 is detrimental to epithelial integrity, 
presence of IL-18 is necessary for IL-22 release by type 3 innate lymphoid cells (ILC3s). c. ILC3-derived IL-22 
promotes mucosal barrier protection by inducing mucin synthesis and goblet cell function. d. In goblet cells, ROS 
triggers the NLRP6 inflammasome to elicit mucin granule secretion. e. Sentinel goblet cells responding to microbial 
triggers can signal to adjacent goblet cells to degranulate via GAP junctions. f. A combination of autophagic 
proteins, endosomes and NADPH oxidase-derived ROS are necessary for mucin granule formation in goblet cells. g. 
Both autophagy and mitophagy are induced by hypoxia. Mitophagy might decrease NLRP3 inflammasome activity, 
reducing processing of IL-1β and IL-18. h. Inhibition of PHD enzymes by ROS or hypoxia stabilizes HIF1α 
transcription factor, regulating barrier protective genes. i. Unimpeded or excessive ROS generation can lead to 
abundant maturation of IL-1β or IL-18 or even inflammasome-mediated cell death (necroptosis/pyroptosis). j. 
Inflammasome-activation of CCR2+ infiltrating monocytes contribute to active IL-1β. Mucosal IL-1β may lead to 
accumulation of IL-17A secreting immune cells.  
 
Figure 3: Reactive oxygen species collateral damage and gastrointestinal disease 
 During active inflammation, reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated within 
the local microenvironment affect collateral tissues to cause damage. Activated, transmigrating neutrophils (PMN) 
consume large amounts of O2 in the generation of amounts of ROS (O2-., OH. and H2O2) in the local milieu. Such O2 
consumption results in localized hypoxia and the stabilization of epithelial HIF.  Epithelial HIF stabilization 
activates a cascade of gene transcription that promotes expression of barrier protective function genes and mucins in 
goblet cells. Within the lamina propria, activation of glial cell inducible nitric oxide synthase and the generation of 
nitric oxide (NO.) results in enteric nerve cell death to result in dysmotility. Smooth muscle responses to oxidant 
stress include increased Ca2+ permeability that perpetuates intestinal dysmotility. An early event in acute mucosal 
inflammation within the gastrointestinal tract is increased vascular permeability and the generation of NO. to 
promote local tissue damage.   
28 
 
Review criteria 
PubMed was searched from 1999 to 2017 for articles using the terms: “reactive oxygen species”, “hydrogen 
peroxide”, “hypoxia”, “microbiota”, “mucosa” and “epithelium” alone or in combination. Articles in English were 
considered on the basis of their relevance to this article's topic. The reference lists of articles were crosschecked for 
additional references. 
 
Acknowledgments 
E.L.C. is supported by NIH grant DK103639 and S.P.C. is supported by NIH grants DK50189 / DK104713 / 
DK095491 / DK103712 and a Merit Award from the Veterans Administration.  
 
Author contributions 
E.L.C researched data for the article. E.L.C and S.P.C made a substantial contribution to discussion of content, 
wrote the article and reviewed/edited the manuscript before submission.  
 
Competing interests statement 
The authors declare no competing interests. 
 
Publisher's note 
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. 
 
References: 
1 France, M. M. & Turner, J. R. The mucosal barrier at a glance. J Cell Sci 130, 307-314, 
doi:10.1242/jcs.193482 (2017). 
2 Crosnier, C., Stamataki, D. & Lewis, J. Organizing cell renewal in the intestine: stem cells, signals and 
combinatorial control. Nat Rev Genet 7, 349-359, doi:10.1038/nrg1840 (2006). 
3 Clevers, H. C. & Bevins, C. L. Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol 75, 
289-311, doi:10.1146/annurev-physiol-030212-183744 (2013). 
29 
 
4 Johansson, M. E. & Hansson, G. C. Immunological aspects of intestinal mucus and mucins. Nat Rev 
Immunol 16, 639-649, doi:10.1038/nri.2016.88 (2016). 
5 Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut 
microbiome. Front Genet 6, 81, doi:10.3389/fgene.2015.00081 (2015). 
6 Taylor, C. T. & Colgan, S. P. Regulation of immunity and inflammation by hypoxia in immunological 
niches. Nat Rev Immunol. 17, 774-785. (2017). 
7 Lewis, J. S., Lee, J. A., Underwood, J. C., Harris, A. L. & Lewis, C. E. Macrophage responses to hypoxia: 
relevance to disease mechanisms. J Leukoc Biol 66, 889-900 (1999). 
8 Campbell, E. L. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized 
oxygen depletion to influence resolution of inflammation. Immunity. 40, 66-77. (2014). 
9 Chang, S. Y., Ko, H. J. & Kweon, M. N. Mucosal dendritic cells shape mucosal immunity. Exp Mol Med 
46, e84, doi:10.1038/emm.2014.16 (2014). 
10 Sun, M., He, C., Cong, Y. & Liu, Z. Regulatory immune cells in regulation of intestinal inflammatory 
response to microbiota. Mucosal Immunol 8, 969-978, doi:10.1038/mi.2015.49 (2015). 
11 Davies, L. C., Jenkins, S. J., Allen, J. E. & Taylor, P. R. Tissue-resident macrophages. Nat Immunol 14, 
986-995, doi:10.1038/ni.2705 (2013). 
12 Semenza, G. L. Oxygen sensing, homeostasis, and disease. NEJM 365, 537-547 (2011). 
13 Semenza, G. L. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 
9, 47-71 (2014). 
14 Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-
dependent proteolysis. Nature 399, 271-275 (1999). 
15 Tanimoto, K., Makino, Y., Pereira, T. & Poellinger, L. Mechanism of regulation of the hypoxia-inducible 
factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Embo J 19, 4298-4309 (2000). 
16 Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. & Murray, L. W. Asparagine hydroxylation of the HIF 
transactivation domain: a hypoxic switch. Science 295, 858-861 (2002). 
17 Sender, R., Fuchs, S. & Milo, R. Revised Estimates for the Number of Human and Bacteria Cells in the 
Body. PLoS Biol. 14, e1002533. (2016). 
30 
 
18 McCracken, V. J. & Lorenz, R. G. The gastrointestinal ecosystem: a precarious alliance among epithelium, 
immunity and microbiota. Cell Microbiol 3, 1-11 (2001). 
19 Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and 
resilience of the human gut microbiota. Nature 489, 220-230, doi:10.1038/nature11550 (2012). 
20 Hamer, H. M. et al. Review article: the role of butyrate on colonic function. Alimentary pharmacology & 
therapeutics 27, 104-119, doi:10.1111/j.1365-2036.2007.03562.x (2008). 
21 Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium 
prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut, doi:10.1136/gutjnl-2013-304833 
(2013). 
22 Eeckhaut, V. et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745-1752, 
doi:10.1136/gutjnl-2012-303611 (2013). 
23 Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory bowel 
diseases 15, 1183-1189, doi:10.1002/ibd.20903 (2009). 
24 Tremaroli, V. & Backhed, F. Functional interactions between the gut microbiota and host metabolism. 
Nature. 489, 242-249. doi: 210.1038/nature11552. (2012). 
25 Campbell, E. L. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized 
oxygen depletion to influence resolution of inflammation. Immunity 40, 66-77 (2014). 
26 Jones, R. M. & Neish, A. S. Redox signaling mediated by the gut microbiota. Free Radic Biol Med. 105, 
41-47. (2017). 
27 Halliwell, B. & Gutteridge, J. M. Role of free radicals and catalytic metal ions in human disease: an 
overview. Methods Enzymol 186, 1-85 (1990). 
28 Kulkarni, A. C., Kuppusamy, P. & Parinandi, N. Oxygen, the lead actor in the pathophysiologic drama: 
enactment of the trinity of normoxia, hypoxia, and hyperoxia in disease and therapy. Antioxid Redox Signal 
9, 1717-1730, doi:10.1089/ars.2007.1724 (2007). 
29 Bedard, K. & Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and 
pathophysiology. Physiol Rev 87, 245-313, doi:10.1152/physrev.00044.2005 (2007). 
30 Biasi, F., Leonarduzzi, G., Oteiza, P. I. & Poli, G. Inflammatory bowel disease: mechanisms, redox 
considerations, and therapeutic targets. Antioxid Redox Signal. 19, 1711-1747. (2013). 
31 
 
31 Bals, R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 1, 141-150. (2000). 
32 Schroeder, B. O. et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-
defensin 1. Nature 469, 419-423, doi:10.1038/nature09674 (2011). 
33 Raschig, J. et al. Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in 
a redox dependent mode of action. PLoS Pathog 13, e1006261, doi:10.1371/journal.ppat.1006261 (2017). 
34 Palmer, R. M., Ferrige, A. G. & Moncada, S. Nitric oxide release accounts for the biological activity of 
endothelium-derived relaxing factor. Nature 327, 524-526, doi:10.1038/327524a0 (1987). 
35 Palmer, R. M., Ashton, D. S. & Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-
arginine. Nature 333, 664-666, doi:10.1038/333664a0 (1988). 
36 Stark, M. E., Bauer, A. J., Sarr, M. G. & Szurszewski, J. H. Nitric oxide mediates inhibitory nerve input in 
human and canine jejunum. Gastroenterology 104, 398-409 (1993). 
37 Stark, M. E. & Szurszewski, J. H. Role of nitric oxide in gastrointestinal and hepatic function and disease. 
Gastroenterology 103, 1928-1949 (1992). 
38 Sessa, W. C. et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide 
synthase. J Biol Chem 267, 15274-15276 (1992). 
39 Xie, Q. W. et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. 
Science 256, 225-228 (1992). 
40 Bredt, D. S. et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 
reductase. Nature 351, 714-718, doi:10.1038/351714a0 (1991). 
41 Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. & Freeman, B. A. Apparent hydroxyl radical 
production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl 
Acad Sci U S A 87, 1620-1624 (1990). 
42 Beckman, J. S. & Koppenol, W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. 
Am J Physiol 271, C1424-1437 (1996). 
43 Poyton, R. O., Castello, P. R., Ball, K. A., Woo, D. K. & Pan, N. Mitochondria and hypoxic signaling: a 
new view. Ann N Y Acad Sci 1177, 48-56, doi:10.1111/j.1749-6632.2009.05046.x (2009). 
44 Riley, P. A. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 
65, 27-33 (1994). 
32 
 
45 Conklin, K. A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. 
Integr Cancer Ther 3, 294-300, doi:10.1177/1534735404270335 (2004). 
46 Church, D. F. & Pryor, W. A. Free-radical chemistry of cigarette smoke and its toxicological implications. 
Environ Health Perspect 64, 111-126 (1985). 
47 Anderson, J. C. et al. Smokers as a high-risk group: data from a screening population. J Clin Gastroenterol 
43, 747-752, doi:10.1097/MCG.0b013e3181956f33 (2009). 
48 van der Heide, F. et al. Differences in genetic background between active smokers, passive smokers, and 
non-smokers with Crohn's disease. Am J Gastroenterol 105, 1165-1172, doi:10.1038/ajg.2009.659 (2010). 
49 Loftus, E. V., Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and 
environmental influences. Gastroenterology 126, 1504-1517 (2004). 
50 Kalogeris, T., Baines, C. P., Krenz, M. & Korthuis, R. J. Ischemia/Reperfusion. Compr Physiol. 7, 113-
170. (2016). 
51 Balaban, R. S., Nemoto, S. & Finkel, T. Mitochondria, oxidants, and aging. Cell 120, 483-495, 
doi:10.1016/j.cell.2005.02.001 (2005). 
52 West, A. P., Shadel, G. S. & Ghosh, S. Mitochondria in innate immune responses. Nat Rev Immunol 11, 
389-402, doi:10.1038/nri2975 (2011). 
53 Genova, M. L. et al. The site of production of superoxide radical in mitochondrial Complex I is not a bound 
ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Lett 505, 364-368 (2001). 
54 Sabharwal, S. S. & Schumacker, P. T. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' 
heel? Nat Rev Cancer 14, 709-721, doi:10.1038/nrc3803 (2014). 
55 McGovern, D. P., Kugathasan, S. & Cho, J. H. Genetics of Inflammatory Bowel Diseases. 
Gastroenterology. 149, 1163-1176 (2015). 
56 Ohsumi, Y. Historical landmarks of autophagy research. Cell Res. 24, 9-23. (2014). 
57 Levine, B., Mizushima, N. & Virgin, H. W. Autophagy in immunity and inflammation. Nature 469, 323-
335, doi:10.1038/nature09782 (2011). 
58 Lemasters, J. J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative 
stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8, 3-5, doi:10.1089/rej.2005.8.3 (2005). 
33 
 
59 Gatliff, J. & Campanella, M. TSPO is a REDOX regulator of cell mitophagy. Biochemical Society 
transactions 43, 543-552, doi:10.1042/bst20150037 (2015). 
60 Ostuni, M. A. et al. Overexpression of translocator protein in inflammatory bowel disease: potential 
diagnostic and treatment value. Inflammatory bowel diseases 16, 1476-1487 (2010). 
61 Timmis, J. N., Ayliffe, M. A., Huang, C. Y. & Martin, W. Endosymbiotic gene transfer: organelle genomes 
forge eukaryotic chromosomes. Nat Rev Genet 5, 123-135, doi:10.1038/nrg1271 (2004). 
62 Stone, J. R. & Yang, S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8, 243-270, 
doi:10.1089/ars.2006.8.243 (2006). 
63 Davies, M. J. Protein oxidation and peroxidation. Biochem J. 473, 805-825. (2016). 
64 Vazquez-Torres, A. & Baumler, A. J. Nitrate, nitrite and nitric oxide reductases: from the last universal 
common ancestor to modern bacterial pathogens. Curr Opin Microbiol. 29, 1-8. (2016). 
65 Zelko, I. N., Mariani, T. J. & Folz, R. J. Superoxide dismutase multigene family: a comparison of the 
CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. 
Free Radic Biol Med 33, 337-349 (2002). 
66 Klinowski, E., Broide, E., Varsano, R., Eshchar, J. & Scapa, E. Superoxide dismutase activity in duodenal 
ulcer patients. Eur J Gastroenterol Hepatol 8, 1151-1155 (1996). 
67 Naito, Y. et al. Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients. J 
Clin Gastroenterol 14 Suppl 1, S131-134 (1992). 
68 Toppo, S., Vanin, S., Bosello, V. & Tosatto, S. C. Evolutionary and structural insights into the multifaceted 
glutathione peroxidase (Gpx) superfamily. Antioxid Redox Signal 10, 1501-1514, 
doi:10.1089/ars.2008.2057 (2008). 
69 Chu, F. F., Doroshow, J. H. & Esworthy, R. S. Expression, characterization, and tissue distribution of a 
new cellular selenium-dependent glutathione peroxidase, GSHPx-GI. J Biol Chem 268, 2571-2576 (1993). 
70 Wingler, K., Muller, C., Schmehl, K., Florian, S. & Brigelius-Flohe, R. Gastrointestinal glutathione 
peroxidase prevents transport of lipid hydroperoxides in CaCo-2 cells. Gastroenterology 119, 420-430 
(2000). 
71 Esworthy, R. S. et al. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol 
Gastrointest Liver Physiol 281, G848-855 (2001). 
34 
 
72 Schrader, M. & Fahimi, H. D. Peroxisomes and oxidative stress. Biochim Biophys Acta 1763, 1755-1766, 
doi:10.1016/j.bbamcr.2006.09.006 (2006). 
73 Knoops, B., Argyropoulou, V., Becker, S., Ferte, L. & Kuznetsova, O. Multiple Roles of Peroxiredoxins in 
Inflammation. Mol Cells 39, 60-64, doi:10.14348/molcells.2016.2341 (2016). 
74 Hampton, M. B. & O'Connor, K. M. Peroxiredoxins and the Regulation of Cell Death. Mol Cells. 39, 72-
76. (2016). 
75 Won, H. Y. et al. Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced 
Foxp3+ regulatory T cells. J Immunol 191, 4029-4037, doi:10.4049/jimmunol.1203247 (2013). 
76 Melhem, H. et al. Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant 
Mechanisms. J Crohns Colitis 11, 871-884, doi:10.1093/ecco-jcc/jjx016 (2017). 
77 Suzuki, T. & Yamamoto, M. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 
system during cellular stress. J Biol Chem 292, 16817-16824, doi:10.1074/jbc.R117.800169 (2017). 
78 Gabig, T. G., Bearman, S. I. & Babior, B. M. Effects of oxygen tension and pH on the respiratory burst of 
human neutrophils. Blood 53, 1133-1139 (1979). 
79 Fox, C. J., Hammerman, P. S. & Thompson, C. B. Fuel feeds function: energy metabolism and the T-cell 
response. Nat Rev Immunol 5, 844-852, doi:nri1710 [pii] 
10.1038/nri1710 [doi] (2005). 
80 Campbell, E. L. & Colgan, S. P. Neutrophils and inflammatory metabolism in antimicrobial functions of 
the mucosa. J Leukoc Biol. 98, 517-522. doi: 510.1189/jlb.1183MR1114-1556R. Epub 2015 Feb 1124. 
(2015). 
81 Geiszt, M. NADPH oxidases: new kids on the block. Cardiovascular research 71, 289-299, 
doi:10.1016/j.cardiores.2006.05.004 (2006). 
82 Rada, B. & Leto, T. L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. 
Contributions to microbiology 15, 164-187, doi:10.1159/000136357 (2008). 
83 Corcionivoschi, N. et al. Mucosal reactive oxygen species decrease virulence by disrupting Campylobacter 
jejuni phosphotyrosine signaling. Cell host & microbe 12, 47-59, doi:10.1016/j.chom.2012.05.018 (2012). 
84 McPhail, L. C., Henson, P. M. & Johnston, R. B., Jr. Respiratory burst enzyme in human neutrophils. 
Evidence for multiple mechanisms of activation. J Clin Invest. 67, 710-716. (1981). 
35 
 
85 Dinauer, M. C., Orkin, S. H., Brown, R., Jesaitis, A. J. & Parkos, C. A. The glycoprotein encoded by the X-
linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. 
Nature 327, 717-720, doi:10.1038/327717a0 (1987). 
86 Werlin, S. L., Chusid, M. J., Caya, J. & Oechler, H. W. Colitis in chronic granulomatous disease. 
Gastroenterology. 82, 328-331. (1982). 
87 Mantovani, A., Sica, A. & Locati, M. Macrophage polarization comes of age. Immunity. 23, 344-346. 
(2005). 
88 Hume, D. A. The Many Alternative Faces of Macrophage Activation. Front Immunol. 6, 
10.3389/fimmu.2015.00370. (2015). 
89 MacMicking, J., Xie, Q. W. & Nathan, C. Nitric oxide and macrophage function. Annu Rev Immunol 15, 
323-350, doi:10.1146/annurev.immunol.15.1.323 (1997). 
90 Rodriguez, P. C. et al. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem 
277, 21123-21129, doi:10.1074/jbc.M110675200 (2002). 
91 Efimova, O., Szankasi, P. & Kelley, T. W. Ncf1 (p47phox) is essential for direct regulatory T cell mediated 
suppression of CD4+ effector T cells. PLoS One 6, e16013, doi:10.1371/journal.pone.0016013 (2011). 
92 Kraaij, M. D. et al. Induction of regulatory T cells by macrophages is dependent on production of reactive 
oxygen species. Proc Natl Acad Sci U S A 107, 17686-17691, doi:10.1073/pnas.1012016107 (2010). 
93 Zheng, L., Kelly, C. J. & Colgan, S. P. Physiologic hypoxia and oxygen homeostasis in the healthy 
intestine. A Review in the Theme: Cellular Responses to Hypoxia. Am J Physiol Cell Physiol. 309, C350-
360. (2015). 
94 Crump, J. A., Sjolund-Karlsson, M., Gordon, M. A. & Parry, C. M. Epidemiology, Clinical Presentation, 
Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella 
Infections. Clin Microbiol Rev. 28, 901-937 (2015). 
95 Barman, M. et al. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. 
Infection and immunity 76, 907-915, doi:10.1128/IAI.01432-07 (2008). 
96 Winter, S. E. et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 
426-429, doi:10.1038/nature09415 (2010). 
36 
 
97 Thiennimitr, P. et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the 
microbiota. Proc Natl Acad Sci U S A 108, 17480-17485, doi:10.1073/pnas.1107857108 (2011). 
98 Niethammer, P., Grabher, C., Look, A. T. & Mitchison, T. J. A tissue-scale gradient of hydrogen peroxide 
mediates rapid wound detection in zebrafish. Nature 459, 996-999, doi:10.1038/nature08119 (2009). 
99 Chang, S. et al. Dual oxidase regulates neutrophil recruitment in allergic airways. Free Radic Biol Med 65, 
38-46, doi:10.1016/j.freeradbiomed.2013.06.012 (2013). 
100 Grasberger, H., El-Zaatari, M., Dang, D. T. & Merchant, J. L. Dual oxidases control release of hydrogen 
peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice. 
Gastroenterology 145, 1045-1054, doi:10.1053/j.gastro.2013.07.011 (2013). 
101 Pircalabioru, G. et al. Defensive Mutualism Rescues NADPH Oxidase Inactivation in Gut Infection. Cell 
host & microbe 19, 651-663, doi:10.1016/j.chom.2016.04.007 (2016). 
102 Walter, J., Britton, R. A. & Roos, S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and 
the Lactobacillus reuteri paradigm. Proc Natl Acad Sci U S A 108 Suppl 1, 4645-4652, 
doi:10.1073/pnas.1000099107 (2011). 
103 Alvarez, L. A. et al. NADPH oxidase-derived H2O2 subverts pathogen signaling by oxidative 
phosphotyrosine conversion to PB-DOPA. Proc Natl Acad Sci U S A 113, 10406-10411, 
doi:10.1073/pnas.1605443113 (2016). 
104 Fujii, N. & Saito, T. Homochirality and life. Chem Rec 4, 267-278, doi:10.1002/tcr.20020 (2004). 
105 Cava, F., de Pedro, M. A., Lam, H., Davis, B. M. & Waldor, M. K. Distinct pathways for modification of 
the bacterial cell wall by non-canonical D-amino acids. EMBO J 30, 3442-3453, 
doi:10.1038/emboj.2011.246 (2011). 
106 Sasabe, J. et al. Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine 
mucosal defence and gut microbiota. Nature microbiology 1, 16125, doi:10.1038/nmicrobiol.2016.125 
(2016). 
107 Lambeth, J. D. & Neish, A. S. Nox enzymes and new thinking on reactive oxygen: a double-edged sword 
revisited. Annu Rev Pathol 9, 119-145 (2014). 
108 Jones, R. M. et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation 
of reactive oxygen species. EMBO J. 32, 3017-3028. (2013). 
37 
 
109 Jones, R. M. et al. Lactobacilli Modulate Epithelial Cytoprotection through the Nrf2 Pathway. Cell Rep. 12, 
1217-1225. (2015). 
110 Alam, A. et al. Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and 
requires formyl peptide receptor 1. Mucosal Immunol 7, 645-655, doi:10.1038/mi.2013.84 (2014). 
111 Babbin, B. A. et al. Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution 
through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol 179, 8112-8121 
(2007). 
112 Leoni, G. et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest. 
123, 443-454. (2013). 
113 Mitra, S. K., Hanson, D. A. & Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell 
motility. Nat Rev Mol Cell Biol. 6, 56-68. (2005). 
114 Alam, A. et al. The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. 
Nature Micro 1, In press (2016). 
115 Chandel, N. S. & Schumacker, P. T. Cellular oxygen sensing by mitochondria: old questions, new insight. J 
Appl Physiol (1985) 88, 1880-1889 (2000). 
116 Hagen, T., Taylor, C. T., Lam, F. & Moncada, S. Redistribution of intracellular oxygen in hypoxia by nitric 
oxide: effect on HIF1alpha. Science 302, 1975-1978. (2003). 
117 Schaible, B., Schaffer, K. & Taylor, C. T. Hypoxia, innate immunity and infection in the lung. Respir 
Physiol Neurobiol. 174, 235-243. (2010). 
118 Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF 
augments tissue barrier function. Cell Host Microbe. 17, 662-671. (2015). 
119 Glover, L. E., Lee, J. S. & Colgan, S. P. Oxygen metabolism and barrier regulation in the intestinal mucosa. 
J Clin Invest. 126, 3680-3688. (2016). 
120 Latz, E. NOX-free inflammasome activation. Blood 116, 1393-1394, doi:10.1182/blood-2010-06-287342 
(2010). 
121 Karhausen, J. et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin 
Invest 114, 1098-1106 (2004). 
38 
 
122 Arteel, G. E., Thurman, R. G. & Raleigh, J. A. Reductive metabolism of the hypoxia marker pimonidazole 
is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 253, 743-
750 (1998). 
123 Arteel, G. E., Thurman, R. G., Yates, J. M. & Raleigh, J. A. Evidence that hypoxia markers detect oxygen 
gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72, 889-895 (1995). 
124 Goethals, L. et al. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and 
potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys 65, 246-254, 
doi:10.1016/j.ijrobp.2006.01.007 (2006). 
125 Hindryckx, P. et al. Intrarectal administration of oxygenated perfluorodecalin promotes healing of murine 
colitis by targeting inflammatory hypoxia. Lab Invest. 91, 1266-1276. (2011). 
126 Niecknig, H. et al. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 
under mild hypoxia. Free Radic Res 46, 705-717, doi:10.3109/10715762.2012.669041 (2012). 
127 Synnestvedt, K. et al. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates 
permeability changes in intestinal epithelia. J Clin Invest 110, 993-1002 (2002). 
128 Cummins, E. P. et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of 
colitis. Gastroenterology 134, 156-165. (2008). 
129 Han, I. O., Kim, H. S., Kim, H. C., Joe, E. H. & Kim, W. K. Synergistic expression of inducible nitric 
oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in 
microglial cells. J Neurosci Res 73, 659-669. (2003). 
130 Morote-Garcia, J. C., Rosenberger, P., Nivillac, N. M., Coe, I. R. & Eltzschig, H. K. Hypoxia-inducible 
factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation 
during intestinal hypoxia. Gastroenterology 136, 607-618, doi:S0016-5085(08)01874-X [pii] 
10.1053/j.gastro.2008.10.037 [doi] (2009). 
131 Robinson, A. et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. 
Gastroenterology 134, 145-155. (2008). 
132 Shah, Y. M. et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent 
inflammatory signaling cascade. Gastroenterology 134, 2036-2048, doi:S0016-5085(08)00440-X [pii] 
10.1053/j.gastro.2008.03.009 [doi] (2008). 
39 
 
133 Giatromanolaki, A. et al. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory 
bowel disease. J Clin Pathol 56, 209-213. (2003). 
134 Mariani, F. et al. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to 
inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett 279, 221-
229, doi:S0304-3835(09)00085-8 [pii] 
10.1016/j.canlet.2009.02.001 [doi] (2009). 
135 Matthijsen, R. A. et al. Enterocyte shedding and epithelial lining repair following ischemia of the human 
small intestine attenuate inflammation. PLoS One 4, e7045, doi:10.1371/journal.pone.0007045 [doi] 
(2009). 
136 Colgan, S. P. & Taylor, C. T. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev 
Gastroenterol Hepatol 7, 281-287, doi:nrgastro.2010.39 [pii] 
10.1038/nrgastro.2010.39 [doi] (2010). 
137 Campbell, E. L. & Colgan, S. P. Neutrophils and inflammatory metabolism in antimicrobial functions of 
the mucosa. J Leukoc Biol 98, 517-522, doi:10.1189/jlb.3MR1114-556R (2015). 
138 Holden, V. I., Breen, P., Houle, S., Dozois, C. M. & Bachman, M. A. Klebsiella pneumoniae Siderophores 
Induce Inflammation, Bacterial Dissemination, and HIF-1alpha Stabilization during Pneumonia. MBio 7, 
doi:10.1128/mBio.01397-16 (2016). 
139 Kirienko, N. V. et al. Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a 
hypoxic response and death. Cell host & microbe 13, 406-416, doi:10.1016/j.chom.2013.03.003 (2013). 
140 Kelly, C. J. et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial 
HIF Augments Tissue Barrier Function. Cell host & microbe 17, 662-671, doi:10.1016/j.chom.2015.03.005 
(2015). 
141 Donohoe, D. R., Wali, A., Brylawski, B. P. & Bultman, S. J. Microbial regulation of glucose metabolism 
and cell-cycle progression in mammalian colonocytes. PLoS One 7, e46589, 
doi:10.1371/journal.pone.0046589 (2012). 
142 Rivera-Chavez, F. et al. Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an 
Aerobic Luminal Expansion of Salmonella. Cell host & microbe 19, 443-454, 
doi:10.1016/j.chom.2016.03.004 (2016). 
40 
 
143 Zambetti, L. P. & Mortellaro, A. NLRPs, microbiota, and gut homeostasis: unravelling the connection. J 
Pathol. 233, 321-330. (2014). 
144 Wen, H., Miao, E. A. & Ting, J. P. Mechanisms of NOD-like receptor-associated inflammasome activation. 
Immunity 39, 432-441, doi:10.1016/j.immuni.2013.08.037 (2013). 
145 Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821-832, doi:10.1016/j.cell.2010.01.040 (2010). 
146 Coccia, M. et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-
17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med 209, 1595-1609, 
doi:10.1084/jem.20111453 (2012). 
147 Neudecker, V. et al. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the 
NLRP3 inflammasome. J Exp Med 214, 1737-1752, doi:10.1084/jem.20160462 (2017). 
148 Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality 
during experimental colitis. Immunity 32, 379-391, doi:10.1016/j.immuni.2010.03.003 (2010). 
149 Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. 
Nature 456, 264-268, doi:10.1038/nature07383 (2008). 
150 Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. 
Science 320, 674-677, doi:10.1126/science.1156995 (2008). 
151 Meissner, F. et al. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from 
patients with chronic granulomatous disease. Blood 116, 1570-1573, doi:10.1182/blood-2010-01-264218 
(2010). 
152 van de Veerdonk, F. L. et al. Reactive oxygen species-independent activation of the IL-1beta 
inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A 107, 
3030-3033, doi:10.1073/pnas.0914795107 (2010). 
153 Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W. & Sheu, S. S. Calcium, ATP, and ROS: a 
mitochondrial love-hate triangle. American journal of physiology. Cell physiology 287, C817-833, 
doi:10.1152/ajpcell.00139.2004 (2004). 
154 Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome 
activation. Nature 469, 221-225, doi:10.1038/nature09663 (2011). 
41 
 
155 Birchenough, G. M., Johansson, M. E., Gustafsson, J. K., Bergstrom, J. H. & Hansson, G. C. New 
developments in goblet cell mucus secretion and function. Mucosal Immunol 8, 712-719, 
doi:10.1038/mi.2015.32 (2015). 
156 Chen, G. Y. & Stappenbeck, T. S. Mucus, it is not just a static barrier. Sci Signal 7, pe11, 
doi:10.1126/scisignal.2005357 (2014). 
157 Johansson, M. E. & Hansson, G. C. Is the intestinal goblet cell a major immune cell? Cell host & microbe 
15, 251-252, doi:10.1016/j.chom.2014.02.014 (2014). 
158 Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal 
Paneth cells. Nature 456, 259-263, doi:10.1038/nature07416 (2008). 
159 Patel, K. K. et al. Autophagy proteins control goblet cell function by potentiating reactive oxygen species 
production. EMBO J 32, 3130-3144, doi:10.1038/emboj.2013.233 (2013). 
160 Wlodarska, M. et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating 
goblet cell mucus secretion. Cell 156, 1045-1059, doi:10.1016/j.cell.2014.01.026 (2014). 
161 Birchenough, G. M., Nystrom, E. E., Johansson, M. E. & Hansson, G. C. A sentinel goblet cell guards the 
colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352, 1535-1542, 
doi:10.1126/science.aaf7419 (2016). 
162 Sankey, E. A. et al. Early mucosal changes in Crohn's disease. Gut 34, 375-381. (1993). 
163 Nowarski, R. et al. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell 163, 1444-1456, 
doi:10.1016/j.cell.2015.10.072 (2015). 
164 Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009, 
doi:10.1126/science.1254009 (2014). 
165 Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. 
Nature 528, 560-564, doi:10.1038/nature16460 (2015). 
166 Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial 
pathogens. Nat Med 14, 282-289, doi:10.1038/nm1720 (2008). 
167 Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. Innate lymphoid cells. Innate lymphoid cells: a 
new paradigm in immunology. Science 348, aaa6566, doi:10.1126/science.aaa6566 (2015). 
42 
 
168 Munoz, M. et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal 
infection. Immunity 42, 321-331, doi:10.1016/j.immuni.2015.01.011 (2015). 
169 Bernink, J. H. et al. Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate 
Lymphoid Cells in the Intestinal Lamina Propria. Immunity 43, 146-160, 
doi:10.1016/j.immuni.2015.06.019 (2015). 
170 Guan, Y., Worrell, R. T., Pritts, T. A. & Montrose, M. H. Intestinal ischemia-reperfusion injury: reversible 
and irreversible damage imaged in vivo. Am J Physiol Gastrointest Liver Physiol 297, G187-196, 
doi:10.1152/ajpgi.90595.2008 (2009). 
171 Wang, D., Mann, J. R. & DuBois, R. N. The role of prostaglandins and other eicosanoids in the 
gastrointestinal tract. Gastroenterology 128, 1445-1461 (2005). 
172 Vane, J. R., Bakhle, Y. S. & Botting, R. M. Cyclooxygenases 1 and 2. Annual review of pharmacology and 
toxicology 38, 97-120 (1998). 
173 Moses, T., Wagner, L. & Fleming, S. D. TLR4-mediated Cox-2 expression increases intestinal 
ischemia/reperfusion-induced damage. J Leukoc Biol 86, 971-980, doi:10.1189/jlb.0708396 (2009). 
174 Blikslager, A. T., Roberts, M. C., Rhoads, J. M. & Argenzio, R. A. Prostaglandins I2 and E2 have a 
synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest 100, 1928-1933, 
doi:10.1172/JCI119723 (1997). 
175 Samuelsson, B. & Hammarstrom, S. Leukotrienes: a novel group of biologically active compounds. Vitam 
Horm 39, 1-30. (1982). 
176 Dennis, E. A. & Norris, P. C. Eicosanoid storm in infection and inflammation. Nat Rev Immunol 15, 511-
523 (2015). 
177 Otamiri, T. Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia 
and reperfusion. Surgery 105, 593-597 (1989). 
178 Eltzschig, H. K., Bratton, D. L. & Colgan, S. P. Targeting hypoxia signalling for the treatment of ischaemic 
and inflammatory diseases. Nat Rev Drug Discov. 13, 852-869. (2014). 
179 Katada, K., Takagi, T., Uchiyama, K. & Naito, Y. Therapeutic roles of carbon monoxide in intestinal 
ischemia-reperfusion injury. J Gastroenterol Hepatol. 30, 46-52. (2015). 
43 
 
180 Younes, M. et al. Oxidative tissue damage following regional intestinal ischemia and reperfusion in the cat. 
Res Exp Med (Berl) 184, 259-264 (1984). 
181 Parks, D. A., Williams, T. K. & Beckman, J. S. Conversion of xanthine dehydrogenase to oxidase in 
ischemic rat intestine: a reevaluation. Am J Physiol 254, G768-774 (1988). 
182 Harrison, R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 
33, 774-797 (2002). 
183 Eisen, A. et al. Ischemic preconditioning: nearly two decades of research. A comprehensive review. 
Atherosclerosis 172, 201-210, doi:10.1016/S0021-9150(03)00238-7 (2004). 
184 Alchera, E., Dal Ponte, C., Imarisio, C., Albano, E. & Carini, R. Molecular mechanisms of liver 
preconditioning. World J Gastroenterol 16, 6058-6067 (2010). 
185 Khoury, J., Ibla, J. C., Neish, A. S. & Colgan, S. P. Antiinflammatory adaptation to hypoxia through 
adenosine-mediated cullin-1 deneddylation. J Clin Invest 117, 703-711. (2007). 
186 Hatakeyama, S. et al. Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase 
Skp1/Cul 1/F-box protein FWD1. Proc Natl Acad Sci U S A 96, 3859-3863. (1999). 
187 Boh, B. K., Smith, P. G. & Hagen, T. Neddylation-Induced Conformational Control Regulates Cullin 
RING Ligase Activity In Vivo. J Mol Biol 409, 136-145. (2011). 
188 Soucy, T. A. et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 
458, 732-736. (2009). 
189 Ehrentraut, S. F. et al. Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular 
inflammatory response. J. Immunol. 190, 392-400 (2013). 
190 Eltzschig, H. K., Sitkovsky, M. V. & Robson, S. C. Purinergic signaling during inflammation. N Engl J 
Med 367, 2322-2333, doi:10.1056/NEJMra1205750 (2012). 
191 Eltzschig, H. K. et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in 
hypoxia. J Exp Med 202, 1493-1505. (2005). 
192 Eltzschig, H. K. Adenosine: an old drug newly discovered. Anesthesiology 111, 904-915, 
doi:10.1097/ALN.0b013e3181b060f2 (2009). 
193 Xu, F. et al. Structure of an agonist-bound human A2A adenosine receptor. Science. 332, 322-327. (2011). 
44 
 
194 Frick, J. S. et al. Contribution of adenosine A2B receptors to inflammatory parameters of experimental 
colitis. J Immunol 182, 4957-4964 (2009). 
195 Aherne, C. M. et al. Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial 
barrier during acute colitis. Mucosal Immunol. 8, 1324-1338. (2015). 
196 Hart, M. L. et al. Hypoxia-Inducible Factor-1alpha-Dependent Protection from Intestinal 
Ischemia/Reperfusion Injury Involves Ecto-5'-Nucleotidase (CD73) and the A2B Adenosine Receptor. J 
Immunol, doi:jimmunol.0903617 [pii] 
10.4049/jimmunol.0903617 (2011). 
197 Hart, M. L., Jacobi, B., Schittenhelm, J., Henn, M. & Eltzschig, H. K. Cutting Edge: A2B Adenosine 
receptor signaling provides potent protection during intestinal ischemia/reperfusion injury. J Immunol 182, 
3965-3968 (2009). 
198 Eltzschig, H. K. et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: 
coordination by extracellular nucleotide metabolism. Blood 104, 3986-3992 (2004). 
199 Elliott, M. R. et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic 
clearance. Nature 461, 282-286 (2009). 
200 Eltzschig, H. K. et al. ATP release from activated neutrophils occurs via connexin 43 and modulates 
adenosine-dependent endothelial cell function. Circ Res 99, 1100-1108. (2006). 
201 Eltzschig, H. K. et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in 
posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. The Journal of 
experimental medicine 198, 783-796, doi:10.1084/jem.20030891 (2003). 
202 Weissmuller, T. et al. PMNs facilitate translocation of platelets across human and mouse epithelium and 
together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest 118, 3682-3692 
(2008). 
203 Madara, J. L. et al. 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits 
chloride secretion from T84 intestinal epithelial cell monolayers. J. Clin. Invest. 91, 2320-2325 (1993). 
204 Huang, C. et al. Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease 
Development in Chronic Granulomatous Disease. Inflamm Bowel Dis. 22, 2794-2801. (2016). 
45 
 
205 Bao, S., Carr, E. D., Xu, Y. H. & Hunt, N. H. Gp91(phox) contributes to the development of experimental 
inflammatory bowel disease. Immunol Cell Biol. 89, 853-860. (2011). 
206 Strober, W., Fuss, I. J. & Blumberg, R. S. The immunology of mucosal models of inflammation. Annu Rev 
Immunol 20, 495-549 (2002). 
207 Abraham, C. & Cho, J. H. Inflammatory Bowel Disease. N. Eng. J. Med. 361, 2066-2076 (2009). 
208 Fournier, B. M. & Parkos, C. A. The role of neutrophils during intestinal inflammation. Mucosal Immunol. 
5, 354-366. (2012). 
209 Schulzke, J. D. et al. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 1165, 294-300 
(2009). 
210 Butto, L. F. & Haller, D. Dysbiosis in intestinal inflammation: Cause or consequence. Int J Med Microbiol. 
306, 302-309. (2016). 
211 Simpson, R. et al. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann 
Surg. 218, 444-453 (1993). 
212 Kuhl, A. A. et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade 
of neutrophils. Gastroenterology 133, 1882-1892, doi:S0016-5085(07)01630-7 [pii] 
10.1053/j.gastro.2007.08.073 [doi] (2007). 
213 Wan, P. et al. Extracellular ATP mediates inflammatory responses in colitis via P2 x 7 receptor signaling. 
Sci Rep 6, 19108, doi:10.1038/srep19108 (2016). 
214 Wright, H. L., Moots, R. J., Bucknall, R. C. & Edwards, S. W. Neutrophil function in inflammation and 
inflammatory diseases. Rheumatology (Oxford). 49, 1618-1631. (2010). 
215 Tian, T., Wang, Z. & Zhang, J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and 
Potential Antioxidant Therapies. Oxid Med Cell Longev 2017, 1-18 (2017). 
216 Hebuterne, X., Filippi, J. & Schneider, S. M. Nutrition in adult patients with inflammatory bowel disease. 
Curr Drug Targets 15, 1030-1038. (2014). 
217 Tso, P., Lee, T. & Demichele, S. J. Lymphatic absorption of structured triglycerides vs. physical mix in a 
rat model of fat malabsorption. Am J Physiol. 277, G333-340. (1999). 
218 Hering, N. A., Fromm, M. & Schulzke, J. D. Determinants of colonic barrier function in inflammatory 
bowel disease and potential therapeutics. J Physiol. 590, 1035-1044. (2012). 
46 
 
219 Capaldo, C. T. & Nusrat, A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 1788, 864-871. 
(2009). 
220 Capaldo, C. T. & Nusrat, A. Claudin switching: Physiological plasticity of the Tight Junction. Semin Cell 
Dev Biol. 42, 22-29 (2015). 
221 Tolstanova, G. et al. Early endothelial damage and increased colonic vascular permeability in the 
development of experimental ulcerative colitis in rats and mice. Lab Invest. 92, 9-21. (2012). 
222 Brown, I. A., McClain, J. L., Watson, R. E., Patel, B. A. & Gulbransen, B. D. Enteric glia mediate neuron 
death in colitis through purinergic pathways that require connexin-43 and nitric oxide. Cell Mol 
Gastroenterol Hepatol. 2, 77-91. (2016). 
223 Scirocco, A. et al. Exposure of Toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human 
colonic smooth muscle cell function. J Cell Physiol 223, 442-450, doi:10.1002/jcp.22053 (2010). 
 
